CONTEXT THERAPEUTICS INC. Retained Earnings
CONTEXT THERAPEUTICS INC. (CNTX) had Retained Earnings of -$154.14 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-05
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$154.14M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$139.58M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$130.90M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$117.88M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$154.14M 10-Q · filed 2026-08-05 |
| 2026-03-31 | -$139.58M 10-Q · filed 2026-05-06 |
| 2025-12-31 | -$130.90M 10-Q · filed 2026-08-05 |
| 2025-09-30 | -$117.88M 10-Q · filed 2025-11-05 |
| 2025-06-30 | -$108.18M 10-Q · filed 2025-08-06 |
| 2025-03-31 | -$99.36M 10-Q · filed 2025-05-07 |
| 2024-12-31 | -$94.78M 10-K · filed 2026-03-23 |
| 2024-09-30 | -$91.44M 10-Q · filed 2024-11-06 |
| 2024-06-30 | -$73.98M 10-Q · filed 2024-08-07 |
| 2024-03-31 | -$71.72M 10-Q · filed 2024-05-08 |
| 2023-12-31 | -$68.05M 10-K · filed 2025-03-20 |
| 2023-09-30 | -$61.28M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$55.41M 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$50.40M 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$44.09M 10-K · filed 2024-03-21 |
| 2022-09-30 | -$40.53M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$36.68M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$32.69M 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$29.25M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$26.16M 10-Q · filed 2021-12-02 |
| 2020-12-31 | -$18.80M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |